Beijing Health Guard Biotechnology, Inc

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China	DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, anogenital human papillomavirus infection, anus disorder, anus neoplasm, cervix disorder, colorectal neoplasm, common wart, digestive system disorder, digestive system neoplasm, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, uterine disorder, vaginal cancer, vaginal disorder, viral infectious disease, viral sexually transmitted disease, vulva cancer, vulvar disease	Active, not recruiting	Phase 3	2022-12-27		NCT05662020

Clinical trials